Kingsview Wealth Management LLC lifted its holdings in shares of Genpact Limited (NYSE:G – Free Report) by 2.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 263,431 shares of the business services provider’s stock after buying an additional 5,216 shares during the period. Kingsview Wealth Management LLC’s holdings in Genpact were worth $11,314,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in G. AQR Capital Management LLC grew its holdings in shares of Genpact by 406.1% during the second quarter. AQR Capital Management LLC now owns 42,506 shares of the business services provider’s stock worth $1,351,000 after purchasing an additional 34,108 shares during the last quarter. Creative Planning grew its stake in Genpact by 30.3% during the 2nd quarter. Creative Planning now owns 25,614 shares of the business services provider’s stock worth $825,000 after buying an additional 5,950 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in Genpact during the 2nd quarter worth approximately $335,000. GAMMA Investing LLC increased its position in Genpact by 221.3% during the third quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider’s stock worth $131,000 after buying an additional 2,293 shares during the period. Finally, Inspire Investing LLC lifted its stake in Genpact by 242.0% in the third quarter. Inspire Investing LLC now owns 37,277 shares of the business services provider’s stock valued at $1,462,000 after buying an additional 26,376 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Genpact Stock Up 11.3 %
G opened at $54.98 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The stock has a market capitalization of $9.70 billion, a P/E ratio of 15.10, a P/E/G ratio of 1.61 and a beta of 1.20. The business has a 50 day simple moving average of $44.92 and a 200-day simple moving average of $41.15.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.24%. This is a boost from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio is currently 16.76%.
Insider Activity at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. This represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 35,058 shares of company stock valued at $1,558,675 in the last ninety days. Corporate insiders own 2.80% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on G shares. Needham & Company LLC lifted their target price on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a report on Friday. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and upped their target price for the company from $45.00 to $60.00 in a report on Friday. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and raised their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Robert W. Baird upped their price objective on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $47.63.
Check Out Our Latest Analysis on G
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Do ETFs Pay Dividends? What You Need to Know
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- The Role Economic Reports Play in a Successful Investment Strategy
- MarketBeat Week in Review – 02/03 – 02/07
- 3 Warren Buffett Stocks to Buy Now
- Meta Platforms Continues to Prove Why It’s a Premier Play on AI
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.